erastin - Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Columbia University, Prolexys
Apelin-13 Protects Against Myocardial Hypoxia/Reoxygenation (H/R) Injury by Inhibiting Ferroptosis Via Nrf2 Activation. (PubMed, J Biochem Mol Toxicol) - Mar 28, 2025 - "These protective actions were negated by the ferroptosis inducer Erastin...Conversely, Nrf2 knockdown nullified the protective effects of Apelin-13 against ferroptosis and cardiomyocyte injury, underscoring the critical involvement of Nrf2 in mediating these benefits. Collectively, our results highlight the promising therapeutic potential of Apelin-13 in managing CAD." 
Journal • Cardiovascular • Coronary Artery Disease • Metabolic Disorders • Reperfusion Injury • FTH1 • GPX4 • HMOX1 • TNNI3
http://www.ncbi.nlm.nih.gov/pubmed/40152053
 
Chen Li; Fan Liang; Yanbo Sui; Yumiao Liu
 
Mar 28, 2025
 
Prev Next